Molnupiravir and COVID-19 Mortality Reduction in the Omicron Era

NCT07720596 · clinicaltrials.gov ↗

COMPLETED

Status

1795570

Enrollment

OTHER

Sponsor class

Conditions

COVID-19
SARS-CoV-2

Interventions

DRUG: Molnupiravir

Sponsor

Charles University, Czech Republic

Collaborators

[object Object]